Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:231736Q15.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome is an extremely rare eye disorder that affects several structures within the eye from birth. The name describes the combination of features seen in this condition: microcornea means the clear front window of the eye (cornea) is smaller than normal; posterior megalolenticonus refers to an abnormal bulging of the back surface of the eye's lens; persistent fetal vasculature means that blood vessels that normally disappear before birth remain present in the eye; and coloboma refers to a gap or missing piece in one or more structures of the eye, such as the iris, retina, or optic nerve. Together, these abnormalities can significantly affect vision from a very early age. Because multiple parts of the eye are affected, children with this syndrome often experience reduced vision or even blindness in one or both eyes. The severity can vary from person to person. Some children may have all of the features described, while others may have only some of them. Additional eye problems such as cataracts (clouding of the lens), glaucoma (increased eye pressure), or retinal detachment may also develop over time. Treatment is primarily supportive and focused on managing individual eye problems. Surgery may be needed for cataracts, glaucoma, or retinal detachment. Visual rehabilitation, including corrective lenses or low-vision aids, can help maximize remaining vision. Early diagnosis and close monitoring by eye specialists are essential to preserve as much vision as possible. There is currently no cure for this syndrome, and management is tailored to each patient's specific combination of eye findings.

Also known as:

Key symptoms:

Smaller than normal cornea (front of the eye)Abnormal bulging of the back of the eye lensBlood vessels in the eye that should have disappeared before birthGap or missing tissue in parts of the eye (coloboma)Reduced vision or poor eyesightClouding of the eye lens (cataract)Increased pressure inside the eye (glaucoma)Abnormal appearance of the pupil or irisWhite reflex in the pupil (leukocoria)Crossed eyes or misaligned eyes (strabismus)Small eye size (microphthalmos)Possible retinal detachment

Clinical phenotype terms (7)— hover any for plain English
Remnants of the hyaloid vascular systemHP:0007968Posterior lenticonusHP:0011502
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome.

View clinical trials →

No actively recruiting trials found for Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome community →

No specialists are currently listed for Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndromeForum →

No community posts yet. Be the first to share your experience with Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome.

Start the conversation →

Latest news about Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome

No recent news articles for Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific eye structures are affected in my child, and how severe is each problem?,What is the expected level of vision my child may have, and could it change over time?,Are there surgeries or treatments that could help improve or preserve my child's vision?,How often should my child have eye exams, and what warning signs should I watch for at home?,Should we pursue genetic testing, and could this condition affect future children?,What early intervention or visual rehabilitation services are available for my child?,Are there any clinical trials or new research studies that might be relevant?

Common questions about Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome

What is Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome?

Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome is an extremely rare eye disorder that affects several structures within the eye from birth. The name describes the combination of features seen in this condition: microcornea means the clear front window of the eye (cornea) is smaller than normal; posterior megalolenticonus refers to an abnormal bulging of the back surface of the eye's lens; persistent fetal vasculature means that blood vessels that normally disappear before birth remain present in the eye; and coloboma refers to a gap or missing piece in on

How is Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome inherited?

Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome typically begin?

Typical onset of Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome is neonatal. Age of onset can vary across affected individuals.